Collectively, these findings further supported that overexpression of BHLHE41 inhibited bladder cancer growth in vivo, which might be associated with the downregulation of PYCR1 and the inactivation of PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and urinary bladder carcinoma.